Cargando…
Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large cell carcinoma
Pulmonary large cell carcinoma - a diagnostically and clinically controversial entity - is defined as a non-small cell carcinoma lacking morphologic differentiation as either adenocarcinoma or squamous cell carcinoma, but suspected to represent an end-stage of poor differentiation of these tumor typ...
Autores principales: | Rekhtman, Natasha, Tafe, Laura J., Chaft, Jamie E., Wang, Lu, Arcila, Maria E., Colanta, Agnes, Moreira, Andre L., Zakowski, Maureen F., Travis, William D., Sima, Camelia S., Kris, Mark G., Ladanyi, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594043/ https://www.ncbi.nlm.nih.gov/pubmed/23196793 http://dx.doi.org/10.1038/modpathol.2012.195 |
Ejemplares similares
-
Using a Panel of Immunomarkers to Define Homologies in Mammalian Brains
por: Watson, Charles R., et al.
Publicado: (2010) -
Role of Immunomarkers in the Clinicopathological Analysis of Unicystic Ameloblastoma
por: Sah, Parul, et al.
Publicado: (2013) -
Immunocytochemistry of effusions: Processing and commonly used immunomarkers
por: Shidham, Vinod B., et al.
Publicado: (2022) -
Quantification of within‐ and between‐farm dispersal of Culicoides biting midges using an immunomarking technique
por: Sanders, Christopher J., et al.
Publicado: (2017) -
KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma
por: Rekhtman, Natasha, et al.
Publicado: (2013)